Fennec Pharmaceuticals (FENC) Cash from Financing Activities (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Cash from Financing Activities of $20.8 million for Q4 2025, up 270.35% year-on-year from $5.6 million in Q4 2024, and up 1089.42% on a QoQ basis from $1.7 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 14 years of Cash from Financing Activities data on file, last reported at $20.8 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities rose 270.35% year-over-year to $20.8 million; the trailing twelve-month figure through Dec 2025 stood at $22.6 million (up 266.19% YoY), and the FY2025 full-year result was $22.6 million, up 266.19% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $20.8 million, up from $1.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $20.8 million in Q4 2025 and bottomed at -$12.2 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is $201000.0 (2023), against an average of $2.1 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities jumped 8140.0%; it then sank 686.53% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $10000.0 in 2021, then surged by 8140.0% to $824000.0 in 2022, then surged by 595.39% to $5.7 million in 2023, then sank by 313.12% to -$12.2 million in 2024, then jumped by 270.35% to $20.8 million in 2025.
- The last three Cash from Financing Activities figures came in at $20.8 million (Q4 2025), $1.7 million (Q3 2025), and -$284000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 20.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.80 Mn |
| Dec 31, 2025 | 20.80 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | -284,000.00 |
| Jun 30, 2025 | -284,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Dec 31, 2024 | -12.21 Mn |
| Dec 31, 2024 | -12.21 Mn |
| Sep 30, 2024 | -528,000.00 |
| Sep 30, 2024 | -528,000.00 |
| Jun 30, 2024 | 257,000.00 |
| Jun 30, 2024 | 257,000.00 |
| Mar 31, 2024 | -1.13 Mn |
| Mar 31, 2024 | -1.13 Mn |
| Dec 31, 2023 | 5.73 Mn |
| Dec 31, 2023 | 5.73 Mn |
| Sep 30, 2023 | 201,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 514,000.00 |
| Jun 30, 2023 | 514,000.00 |
| Mar 31, 2023 | 193,000.00 |
| Mar 31, 2023 | 193,000.00 |
| Dec 31, 2022 | 824,000.00 |
| Dec 31, 2022 | 824,000.00 |
| Sep 30, 2022 | 19.85 Mn |
| Sep 30, 2022 | 19.85 Mn |
| Jun 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 462,000.00 |
| Dec 31, 2020 | 462,000.00 |
| Sep 30, 2020 | -117,000.00 |
| Sep 30, 2020 | -117,000.00 |
| Jun 30, 2020 | 31.94 Mn |
| Jun 30, 2020 | 31.94 Mn |
| Mar 31, 2019 | -71,000.00 |
| Mar 31, 2019 | -71,000.00 |
| Dec 31, 2018 | 1.19 Mn |
| Dec 31, 2018 | 1.19 Mn |
| Sep 30, 2018 | 483,000.00 |
| Sep 30, 2018 | 483,000.00 |
| Jun 30, 2018 | 491,000.00 |
| Jun 30, 2018 | 491,000.00 |
| Mar 31, 2018 | 186,000.00 |
| Mar 31, 2018 | 186,000.00 |
| Dec 31, 2017 | 19.89 Mn |
| Dec 31, 2017 | 19.89 Mn |
| Sep 30, 2017 | 414,000.00 |
| Sep 30, 2017 | 414,000.00 |
| Jun 30, 2017 | 7.67 Mn |
| Jun 30, 2017 | 7.67 Mn |
| Jun 30, 2016 | 5.01 Mn |
| Jun 30, 2016 | 5.01 Mn |
| Mar 31, 2016 | 102,000.00 |
| Mar 31, 2016 | 102,000.00 |
| Sep 30, 2015 | 21,000.00 |
| Sep 30, 2015 | 21,000.00 |
| Jun 30, 2015 | 449,000.00 |
| Jun 30, 2015 | 449,000.00 |
| Mar 31, 2015 | 27,000.00 |
| Mar 31, 2015 | 27,000.00 |
| Dec 31, 2014 | 2.18 Mn |
| Dec 31, 2014 | 2.18 Mn |
| Sep 30, 2014 | 21,000.00 |
| Sep 30, 2014 | 21,000.00 |
| Jun 30, 2014 | 87,000.00 |
| Jun 30, 2014 | 87,000.00 |
| Mar 31, 2014 | 53,000.00 |
| Mar 31, 2014 | 53,000.00 |
| Dec 31, 2013 | 1.57 Mn |
| Dec 31, 2013 | 1.57 Mn |
| Jun 30, 2010 | 7.19 Mn |
| Jun 30, 2010 | 7.19 Mn |